Literature DB >> 2521784

Ultrastructural aspects of atrium development: demonstration of endocardial discontinuities and immunolabeling of atrial natriuretic factor in the Syrian hamster.

J Gilloteaux1.   

Abstract

The endocardium ultrastructure of 13 embryonic day old hamsters was examined, especially in relationship with the atrial myocytes. The endothelial morphology was described, including the junctional attachments and their relationships with subjacent atrial myocytes. Characteristic atrial myocytes organelles were identified: myofibrils, atrial granules, lipidic inclusions, and polysomes. Immunogold labeling demonstrated that atrial natriuretic factor (ANF)-containing granules were already present in the differentiating cardiomyocytes, even before the myofibrils were completely organized. At this stage of development, while the endothelium was a narrow barrier between the blood and the cardiomyocytes, it displayed fenestrations, but also epithelial discontinuities. In addition it also contains immunoreactive-ANF products. In light of the current knowledge about ANF processing it was proposed that the endocardium lining could be an obligated passageway for transport or activating proANF into ANF before its release into the blood stream. In addition the endocardial gaps could suggest that, until about 13 to 14 days of fetal development, heart atrial tissue could be more susceptible to the effects of pathogenetic compounds than in a later state of development.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521784     DOI: 10.1007/bf00326587

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  58 in total

1.  Endocardial surface structures of the feline heart observed with a scanning electron microscope.

Authors:  S H Song
Journal:  Acta Anat (Basel)       Date:  1977

2.  Scanning electron microscopy of mouse endocardium and vanae cordis minimae foramina.

Authors:  K F Maguire
Journal:  Z Anat Entwicklungsgesch       Date:  1972

3.  Ultrastructure research of the endocardial endothelium of monkeys.

Authors:  H Harasaki; I Suzuki; J Tanaka; H Hanano; M Torisu
Journal:  Arch Histol Jpn       Date:  1975-06

4.  The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties.

Authors:  T G Flynn; M L de Bold; A J de Bold
Journal:  Biochem Biophys Res Commun       Date:  1983-12-28       Impact factor: 3.575

5.  Micropuncture studies of the renal effects of atrial natriuretic substance.

Authors:  J P Briggs; B Steipe; G Schubert; J Schnermann
Journal:  Pflugers Arch       Date:  1982-12       Impact factor: 3.657

6.  Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.

Authors:  H D Kleinert; T Maack; S A Atlas; A Januszewicz; J E Sealey; J H Laragh
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

7.  Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity.

Authors:  K S Misono; H Fukumi; R T Grammer; T Inagami
Journal:  Biochem Biophys Res Commun       Date:  1984-03-15       Impact factor: 3.575

8.  Intrarenal localization of the natriuretic effect of cardiac atrial extract.

Authors:  H Sonnenberg; W A Cupples; A J de Bold; A T Veress
Journal:  Can J Physiol Pharmacol       Date:  1982-09       Impact factor: 2.273

9.  Atrial natriuretic factor has a direct, prostaglandin-independent action on kidneys.

Authors:  R Keeler
Journal:  Can J Physiol Pharmacol       Date:  1982-08       Impact factor: 2.273

10.  Presence of cytochrome P-450-dependent monooxygenase in intimal cells of the hog aorta.

Authors:  N G Abraham; A Pinto; K M Mullane; R D Levere; E Spokas
Journal:  Hypertension       Date:  1985 Nov-Dec       Impact factor: 10.190

View more
  1 in total

1.  Immunocytochemical studies of cardiac myocytes and other non-neuronal cells of the fetal human heart in culture.

Authors:  C J Hassall; R Penketh; C Rodeck; G Burnstock
Journal:  Anat Embryol (Berl)       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.